ESMO 2023 Insights: "The GCIG INTERLACE Randomised Phase 3 Trial of Induction Chemo Followed by CRT Compared With CRT Alone in Locally Advanced Cervical Cancer"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

0:00

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

ESMO 2023 Insights: "The GCIG INTERLACE Randomised Phase 3 Trial of Induction Chemo Followed by CRT Compared With CRT Alone in Locally Advanced Cervical Cancer"

By Insights from 2023 ESMO Annual Meeting FEATURING Mary McCormack

0 views

October 26, 2023

Comments 0

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

Feat. R. Salani